I Quit Ordinary Smoking (IQOS)

SINGAPORE (Dec 6): UOB KayHian is maintaining Venture Corp at “sell” given increasing risk production share of IQOS (I quit ordinary smoking) devices could be shifted away to another contract manufacturer by Philip Morris which is seeking to improve e

SINGAPORE (Oct 19): UOB Kay Hian is maintaining its “hold” call on Venture Corporation with a target price of $18.20.

SINGAPORE (Oct 2): UOB Kay Hian is maintaining its “hold” call on Venture Corporation with a recommended entry price of $16 and target price of $18.20, which is pegged to 14 times 2018F P/E.

SINGAPORE (Aug 6): RHB Research is maintaining “buy” on Venture Corp while lowering its target price from $26 to $22.20, which is now pegged to 15.5 times FY18F P/E compared to 17.2 times previously due to the weaker industry outlook.

SINGAPORE (July 23): Philip Morris International has significantly cut its full-year guidance as it prepares for the next generation of IQOS (I quit original smoking) devices.

SINGAPORE (July 5): Venture Corp’s stellar 2017 was driven by I Quit Ordinary Smoking (IQOS) smokeless cigarette devices.

SINGAPORE (May 8): Citigroup is keeping Venture Corp at “buy” with unchanged $31.74 target, saying sales contribution by Philip Morris International’s looks closer to 12% than the 30% feared by investors.

SINGAPORE (Apr 24): UOB Kay Hian is maintaining its “buy” call on Venture Corporation with a lower target price of $30.60.